HOME
ABOUT
PORTFOLIO
_
TEAM
NEWS
CONTACT
More
Indigo Ag announces an additional $360M in financing, appoints Stéphane Bancel, Moderna CEO, to Boar
Sana Biotechnology Announces Completion of Initial Financing
Escient Pharmaceuticals Announces $120 Million Series C Financing
Indigo Expands 2023 Biological Crop Protection Line with New Biofungicide
Neumora Therapeutics Announces $112 Million Series B Financing
eFFECTOR Therapeutics Doses First Patient in Second Cohort of Phase 1b Clinical Trial of Zotatifin
Nature Medicine Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of GRANITE
Gritstone Announces Updated Overall Survival Results in CRC Patients from Phase 1/2 Study of GRANITE
Tessera Therapeutics Announces Over $300M Series C Financing to Advance its GENE WRITING Platform
Ansa Biotechnologies Closes Oversubscribed $68 Million Series A Financing
eFFECTOR Therapeutics Provides Pipeline and Business Updates
Nuvation Bio Announces FDA Clearance of IND Application for NUV-868 for the Advanced Solid Tumors
